Related Experiment Videos

Interactions between mycoplasma pneumoniae and the first components of complement

Infection and Immunity
|January 1, 1977
PubMed

Insights

Mycoplasma pneumoniae can be killed by guinea pig serum through an antibody-independent complement activation pathway. This involves the binding of the first component of complement (C1) to the mycoplasma surface, leading to cell death.

Area of Science:

  • Immunology
  • Microbiology
  • Complement System

Background:

  • Mycoplasma pneumoniae is a significant human pathogen.
  • The complement system is a crucial part of innate immunity.
  • Antibody-dependent complement activation is a well-established mechanism.

Purpose of the Study:

  • To investigate the mechanism of Mycoplasma pneumoniae killing by fresh guinea pig serum (GPS).
  • To determine if complement activation by M. pneumoniae is antibody-dependent.
  • To explore the interaction between M. pneumoniae and early complement components.

Main Methods:

  • Incubation of M. pneumoniae with fresh guinea pig serum (GPS) and purified complement components.
  • Quantification of C1 binding to M. pneumoniae cells.
  • Sequential addition of complement components (C1, C4, C2) to assess complement pathway activation.
  • Microscopic observation of cell morphology changes (rounding) and viability assays.

Main Results:

  • M. pneumoniae was killed by fresh GPS lacking detectable antibodies.
  • Significant binding of the first component of complement (C1) to M. pneumoniae was observed.
  • Sequential addition of C1, C4, and C2 led to cell rounding, indicating complement activation.
  • M. orale and M. fermentans showed reduced C1 binding and slower killing compared to M. pneumoniae.

Conclusions:

  • M. pneumoniae activates the complement system via an antibody-independent mechanism.
  • The cell surface of M. pneumoniae directly interacts with C1, initiating complement cascade.
  • This interaction leads to complement-mediated killing of M. pneumoniae.

Related Concept Videos